|
Composition of Pharmaceutical HOLDRS
The specific share amounts for each round-lot of 100
Pharmaceutical HOLDRS are set forth in the table below. The share amounts specified will not change
except for changes due to corporate actions or reconstitution events. Component list as of 03/22/04.
| Company Name | Symbol | # of shares | % Weight |
| Abbott Laboratories | ABT | 14.00 | 7.44% |
| Advanced Medical Optics Inc | AVO | 0.22 | 0.07% |
| Allergan, Inc. | AGN | 1.00 | 1.13% |
| Andrx Corp Del | ADRX | 2.00 | 0.76% |
| Biovail Corp | BVF | 4.00 | 0.88% |
| Bristol-Myers Squibb Company | BMY | 18.00 | 6.00% |
| Eli Lilly and Company | LLY | 10.00 | 9.07% |
| Forest Laboratories, Inc. | FRX | 4.00 | 3.76% |
| IVAX Corporation | IVX | 1.88 | 0.58% |
| Johnson & Johnson | JNJ | 26.00 | 17.20% |
| King Pharmaceuticals Inc | KG | 4.25 | 0.90% |
| Medco Health Solutions Inc | MHS | 2.65 | 1.14% |
| Merck & Co., Inc. | MRK | 22.00 | 12.73% |
| Mylan Laboratories Inc. | MYL | 2.25 | 0.67% |
| Pfizer Inc | PFE | 58.00 | 26.03% |
| Schering-Plough Corporation | SGP | 14.00 | 3.06% |
| Valeant Pharmaceuticals Intl | VRX | 1.00 | 0.32% |
| Watson Pharmaceuticals Inc | WPI | 1.00 | 0.59% |
| Wyeth | WYE | 12.00 | 5.90% |
| Zimmer Hldgs Inc | ZMH | 1.80 | 1.78% |
Download the component list
|
|
|
Trading Units
A round
lot is 100 HOLDRS. Odd lots (fewer than 100 HOLDRS) WILL NOT
TRADE.
|
|
Price
Quotations
Quoted in dollars and fractions of a dollar per HOLDRS.
Minimum “tick” is 1/16th ($0.0625). |
|
How to Purchase or Sell
Pharmaceutical HOLDRS
Pharmaceutical HOLDRS may be acquired in two ways:
- through the deposit of the required number of shares of common stock of the
underlying issuers with the trustee, or
- through a cash purchase in the secondary trading market.
Pharmaceutical HOLDRS may be disposed of in two ways:
- Pharmaceutical HOLDRS may be canceled by turning them into the trustee, The
Bank of New York, and withdrawing the underlying securities, or
- Pharmaceutical HOLDRS may be sold on the secondary market.
|
|
Selling Short
Exempt
from SEC Rule 10a-1(short sale rule). |
|
Life of Pharmaceutical
HOLDRS Trust
The Pharmaceutical HOLDRS Trust will terminate should any of
the following occur:
- The Pharmaceutical HOLDRS are delisted from The American Stock Exchange and
are not listed for trading on another national securities exchange or through
Nasdaq within 5 business days from the date of delisting.
- The Trustee resigns and no successor trustee is appointed within 60 days
from the date the trustee provides notice of its intent to resign.
- 75% of beneficial owners of outstanding Pharmaceutical HOLDRS vote to
dissolve and liquidate the trust.
- Final termination date December 31, 2040.
If a termination event occurs, the trustee will distribute the underlying
securities to owners as promptly as practicable after the termination
event. |
|
Shares
Outstanding
The number of outstanding Pharmaceutical HOLDRS will increase
and decrease as a result of deposits and withdrawals of the underlying
securities. The trust will stand ready to issue additional Pharmaceutical HOLDRS
on a continuous basis when an investor deposits the required shares of common
stock with the trustee. |
|
Fees and
Expenses
Custody Fees: The Bank of New York, as trustee and
custodian, will charge you a quarterly custody fee of $2.00 for each round-lot
of 100 Pharmaceutical HOLDRS to be deducted from any cash dividend or other cash
distribution on underlying securities received by the trust. The Trustee will
waive any portion of the custody fee which exceeds the total cash dividends and
other cash distributions received.
Issuance and Cancellation Fees:
Pharmaceutical HOLDRS may be created by delivering to the trust the
requisite whole shares of common stock evidencing an Pharmaceutical HOLDRS , The
Bank of New York as trustee will charge an issuance fee of up to $10.00 for each
round-lot of 100 Pharmaceutical HOLDRS . To cancel Pharmaceutical HOLDRS and
withdraw the underlying securities, The Bank of New York as trustee will charge
a cancellation fee of up to $10.00 for each round-lot of 100 Pharmaceutical
HOLDRS . You can only deposit or cancel Pharmaceutical HOLDRS on an in-kind
basis in round-lots of 100 Pharmaceutical HOLDRS. |
|
Minimum Customer
Margin
For purchases, 50%; for short sales, 150%. |
|
Settlement
Date
For trades, three New York business days. HOLDRS are in book-entry
form held at The Depository Trust Company (DTC). |
|
Settlement
Next New York business day following
expiration. |
|
Trading
Hours
9:30 a.m. to 4 p.m. New York time. |
|
Trading
System
Specialist/Registered Options Trader. |
|
CUSIP
Number
717 12A 20 6 |
|
|
The information
in this specification sheet is not complete and may be changed. For complete
details regarding rights relating to Pharmaceutical HOLDRS and rights relating
to the underlying securities please refer to the prospectus. This is not an
offer to sell Pharmaceutical HOLDRS and we are not soliciting offers to buy
Pharmaceutical HOLDRS in any state where such offer or sale is not
permitted.
“HOLDRS” and
“HOLding Company Depositary Receipts” are service
marks of Merrill Lynch & Co., Inc.
|
